Results 161 to 170 of about 41,337 (280)

Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact—a study of 784 patients from the Quebec MPN research group

open access: yesBlood Cancer Journal
Alisa Poullet   +13 more
doaj   +1 more source

Three New Species of Thelymitra (Diurideae, Orchidaceae) Endemic to Aotearoa New Zealand

open access: yesNew Zealand Journal of Botany, Volume 64, Issue 4, December 2026.
Three new species of sun orchid (Thelymitra) endemic to Aotearoa New Zealand are here described: T. palustris, T. scabrifolia and T. semaphora. These new species were previously known under the tag‐names Thelymitra (a) (WELT SP79140; Ahipara), Thelymitra (c) (AK 229531; ‘rough leaf') and Thelymitra (b) (CHR 518036; ‘darkie'), respectively.
H. R. Jones, J. A. Tate, C. A. Lehnebach
wiley   +1 more source

Assessment of Oxidative Stress, Vitellogenin, and Human Health Risks Derived From Nile Tilapia Exposed to Metals and Metalloids in Southeastern Brazil

open access: yesEnvironmental Toxicology, Volume 41, Issue 12, Page 1701-1725, December 2026.
ABSTRACT Urban coastal lagoons are highly vulnerable ecosystems increasingly affected by metal contamination, as well as multiple anthropogenic stressors. This study evaluated ecotoxicological and human health risks associated with chronic metal exposure in Nile tilapia ( Oreochromis niloticus ) from an anthropogenically impacted lagoon in southeastern
Julia Araújo Alves   +8 more
wiley   +1 more source

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1421-1441, December 2026.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto   +12 more
wiley   +1 more source

PO110 | CLINICAL OUTCOMES AND SURVIVAL OF UNUSUAL SITE VENOUS THROMBOSIS IN PATIENTS WITH AND WITHOUT MYELOPROLIFERATIVE NEOPLASMS: A RETROSPECTIVE SINGLE-CENTER STUDY

open access: yesBleeding, Thrombosis and Vascular Biology
Background and Aims. Unusual site venous thromboses (USVT) are rare conditions involving the cerebral (CVT), splanchnic (SVT), renal, retinal, and gonadal veins.
Irene Bertozzi
doaj  

Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1531-1540, December 2026.
ABSTRACT Introduction Central venous catheter (CVC) insertion is frequently required in patients with haematological diseases. Despite limited evidence, thrombocytopenia often prompts prophylactic platelet transfusion before catheterisation. Methods We conducted an observational before‐and‐after study including the first non‐tunnelled CVC insertion ...
Mathias Lazarevic Lindblad   +8 more
wiley   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1485-1499, December 2026.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Home - About - Disclaimer - Privacy